| ZRG1 HSS-F (50) |
PAR Panel: Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations |
Dr. Shareen Iqbal |
| ZRG1 IIDA-B (50) |
RFA-RM-25-006: Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed) |
Dr. Anna Babakhanyan |
| ZRG1 IIDB-F (02) |
Member Conflict: Topics on Autoimmunity, Immunology and Transplantation |
Dr. Philip Owens |
| ZRG1 IIDB-K (72) |
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) |
Dr. Kristina Wickham |
| ZRG1 IIDB-N (81) |
Bacterial Innate Immunomodulation and Pathogenesis |
Dr. Mairi Noverr |
| ZRG1 IIDB-Q (70) |
NIH Director's New Innovator Award Program |
Dr. Vishakha Sharma |
| ZRG1 IIDB-T (72) |
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) |
Dr. Anuja Mathew |
| ZRG1 IIDB-Y (70) |
NIH Director's New Innovator Award Program |
Dr. Marci Scidmore |
| ZRG1 IIDB-Z (70) |
NIH Director's New Innovator Award Program |
Dr. Marcus Ferrone |
| ZRG1 ISB-P (57) |
PAR Panel: Academic Industrial Partnerships for Translation of Medical Technologies
|
Dr. Weihua Luo |
| ZRG1 KUDS-K (92) |
Understanding Mechanistic Impacts of Micro- and Nanoplastics in Organ/Tissue Dysfunction |
Dr. Leroy Worth |
| ZRG1 KUDS-M (55) |
RFA-AI-25-018: Mucosal Immunology Studies Team (MIST) (U01) |
Dr. Marilyn Moore-Hoon |
| ZRG1 KUDS-M (90) |
RFA-AI-25-018: Mucosal Immunology Studies Team (MIST) (U01) |
Dr. Marilyn Moore-Hoon |
| ZRG1 MCST-B (56) |
RFA-CA-25-002: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33) |
Dr. Marie-Jose Belanger |
| ZRG1 MCST-K (85) |
Bioanalytical, Molecular, Cellular Sciences and Technologies |
Dr. Michael Knapp |
| ZRG1 MCST-N (85) |
Bioanalytical, Molecular, Cellular Sciences and Technologies |
Dr. Katherine Shim |
| ZRG1 MCST-U (55) |
PAR Panel: Innovative Research in Cancer Nanotechnology |
Dr. Raj Krishnaraju |
| ZRG1 MGG-R (80) |
Special Topics in Genomics and Therapeutics for Genetic Diseases |
Dr. Dharmendar Rathore |
| ZRG1 MGG-T (50) |
PAR-23-124: Genomic Community Resources (U24) |
Dr. Maryam Ganjehzadeh Rohani |
| ZRG1 MGG-V (70) |
RFA-RM-24-008: Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required) |
Dr. Mollie Manier |
| ZRG1 MGG-W (80) |
Special Topics in Molecular Genetics, Genomics, Genetic Evolution, and Prokaryotic Biology |
Dr. Marcienne Wright |
| ZRG1 MSOS-A (52) |
PAR Panel: Regenerative Medicine Innovation Projects (RMIP) (U01/UH3) |
Dr. Amber Collins |
| ZRG1 NV-C (41) |
P Series: Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional) |
Dr. Cristina Backman |
| ZRG1 NV-E (50) |
RFA Panel: Novel tools to study cell-and circuit-specific brain processes |
Dr. Sudhirkumar Yanpallewar |
| ZRG1 NV-L (50) |
RFA Panel: Neurotherapeutic Agent Identification with Innovation Grants to Nurture Initial Translational Efforts (IGNITE) |
Dr. Elizabeth Litvina |
